Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ANTHEM BIOSCIENCES LTD.

NSE : ANTHEMBSE : 544449ISIN CODE : INE0CZ201020Industry : Pharmaceuticals & DrugsHouse : Private

BSE863.5032.75 (+3.94 %)

PREV CLOSE ( ) 830.75

OPEN PRICE ( ) 839.55

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 70012

TODAY'S LOW / HIGH ( )834.70 871.00

52 WK LOW / HIGH ( )701.75 865

NSE864.5032.7 (+3.93 %)

PREV CLOSE( ) 831.80

OPEN PRICE ( ) 836.00

BID PRICE (QTY) 864.50 (4919)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1170779

TODAY'S LOW / HIGH( ) 835.10 870.00

52 WK LOW / HIGH ( )701.9 864.9

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 13-06 2006

Management Info

Ajay Bhardwaj - Chairman Ajay Bhardwaj - Managing Director

Registered Office

Address No. 49, F1 & F2, Canara Bank Road,Bommasandra Industrial Area,Phase I, Bommasandra,
Bengaluru,
Karnataka-560099

Phone 080-66724000

Email investors.abl@anthembio.com

Website www.anthembio.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

14Aug Anthem Biosciences reports 65% jump in
Anthem Biosciences has reported result for first quarter ended June 30,..

14Aug Anthem Biosciences trades jubilantly o
Anthem Biosciences is currently trading at Rs. 824.00, up by 69.30 point..

21Jul Anthem Biosciences lists with 27% prem
Anthem Biosciences has debuted at Rs 723.10 on the BSE, up by 153.1 poin..

17Jul New Listing
Notice No. 20250718-44 Notice Date 18 Jul 2025Category Company r..

11Jul Anthem Biosciences coming with IPO to
Anthem BiosciencesAnthem Biosciences is coming out with a 100% book buil..

Financials

Rs. in Millions

	QTR Jun 25	ANNUAL
Net Profit	1483.41
Gross Profit	1989.39
Operating Profit	2231.57
Net Sales

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Astrazeneca Pharma I (BSE) 9139.40 (1.34%)	M.Cap ( in Cr)22848.50
Caplin Point Lab (BSE) 2331.50 (3.85%)	M.Cap ( in Cr)17722.13
Pfizer (BSE) 5203.60 (1.26%)	M.Cap ( in Cr)23805.29
Panacea Biotec (BSE) 460.30 (6.15%)	M.Cap ( in Cr)2819.37
Sanofi India (BSE) 5052.45 (0.46%)	M.Cap ( in Cr)11636.11

Shareholding Pattern

	PROMOTERS	74.69%
	NON-INSTITUTION	20.22%
	MUTUAL FUNDS/UTI	2.21%
	FI/BANKS/INSURANCE	1.17%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

ANTHEM BIOSCIENCES LTD.